1. Home
  2. VIOT vs MAIA Comparison

VIOT vs MAIA Comparison

Compare VIOT & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VIOT

Viomi Technology Co. Ltd

HOLD

Current Price

$0.91

Market Cap

65.8M

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.30

Market Cap

77.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIOT
MAIA
Founded
2014
2018
Country
China
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.8M
77.1M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
VIOT
MAIA
Price
$0.91
$1.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
152.0K
547.8K
Earning Date
03-25-2026
05-12-2026
Dividend Yield
13.49%
N/A
EPS Growth
N/A
33.33
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.04
N/A
P/E Ratio
$3.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$0.87
52 Week High
$4.33
$3.19

Technical Indicators

Market Signals
Indicator
VIOT
MAIA
Relative Strength Index (RSI) 33.06 47.43
Support Level N/A $1.24
Resistance Level $1.05 $1.46
Average True Range (ATR) 0.04 0.08
MACD 0.00 0.00
Stochastic Oscillator 20.44 33.19

Price Performance

Historical Comparison
VIOT
MAIA

About VIOT Viomi Technology Co. Ltd

Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

Share on Social Networks: